% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kretchmard kretchmard Nov 29, 2006 7:47 PM Flag


    I would take a more conservative approach. Discounting for present value, and assuming DVAX is a one-hit wonder, and all of their other drugs have no value.

    500M in sales, 60% PM, 58M shares out (one or two equity offerings) equals about $5/share in earnings.

    Giving it a PE of 20 means DVAX is only worth about $100/share today.

    So the market is discounting a lot of unknowns. Is there any independent verification? The numbers sound too good to be true.

    I just can't see pipeline starving big pharmas leaving this stock alone. I do agree that further appreciation is probable. After a correction DVAX could easily move toward the middle teens.

    Good luck to all!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • thank you! BUT allergy drug is HUGE. + all new vaccines for anthrax, cancer, etc. For goodness sakes they're changing the dna and the the way the human immune system fights diseases. This is "unbelieveable"

      However, you're the first to make sense.


      • 1 Reply to jbird408
      • I purchased this stock only as an afterthought and far after I was doing my own research on hay fever since I suffer each and every September for two solid and misserable months. I take steroid shots, medrol dose packs, and all the other routine pills that don't really do anything at all. So while doing research on my problem I came across this company information and thought - where have you been all my life - now I have to suffer through the wait... so if I make a million on this great - if they solve my problem that's worth a millions to me. Only those that suffer to the degree I do can understand that.

11.14+0.23(+2.11%)Sep 28 4:00 PMEDT